RiverPark Advisors’s CareDx CDNA Stock Holding History

RiverPark Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,624	Closed	-$149K	–	141
2025 Q2	$149K	Buy	+7,624	New	+$135K	0.09%	86

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

RiverPark Advisors's CDNA Position: Q3 2025 in Review

RiverPark Advisors sold out of CareDx (CDNA) in Q3 2025, closing a stake of 7,624 shares — an estimated $149K sold.

RiverPark Advisors first reported a position in CDNA in Q2 2025 and held it in 1 quarter. The position peaked at $149K in Q2 2025. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

RiverPark Advisors reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
RiverPark Advisors sold 7,624 CareDx shares in Q3 2025, an estimated $149K.
RiverPark Advisors first reported a position in CareDx in Q2 2025 and held it in 1 quarter.
RiverPark Advisors's CareDx position peaked at $149K in Q2 2025.
187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on RiverPark Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.